AstraZeneca Annual Report and Financial Statements 78 Form 20-F Information 2003 Notes to the Financial Statements continued 11 Fixed asset investments Joint Other ventures investments Total $m $m $m Cost At beginning of year 134 46 180 Additions 120 120 Disposals and other movements, including exchange 54 54 At end of year 134 220 354 Share of post-acquisition reserves At beginning and end of year 134 134 Net book value at 31 December 2003 220 220 Net book value at 31 December 2002 46 46 The fair values of other investments are not materially different from their carrying values.
At 31 December 2003, the Groups share ownership trusts held 1,668,299 Ordinary Shares.
Share of joint venture assets and liabilities 2003 2002 $m $m Gross assets 174 107 Gross liabilities 174 107 12 Stocks 2003 2002 $m $m Raw materials and consumables 715 756 Stocks in process 1,206 1,071 Finished goods and goods for resale 1,101 766 3,022 2,593 The 2002 stock analysis has been recategorised.
